Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
alpha tocopherol + memantine
- Development stage
- Unknown
- Lead developer
- VA Cooperative Studies Program
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
This is a combination therapy consisting of alpha tocopherol (vitamin E) and memantine. Alpha tocopherol is a fat-soluble antioxidant that protects cell membranes from oxidative damage, while memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist that modulates glutamatergic neurotransmission. The combination has been studied primarily for the treatment of mild to moderate Alzheimer's disease, with the hypothesis that their different mechanisms—neuroprotection via antioxidant effects and reduction of excitotoxicity—might provide additive or synergistic benefits. However, clinical trials have shown that the combination does not significantly delay functional decline compared to placebo or either agent alone in this population[2][5][6].
- Other names
- vitamin E + memantinealpha-tocopherol + memantine
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on alpha tocopherol + memantine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on alpha tocopherol + memantine.